240. New Antimicrobial Drug Development: Saturday, 12:15 - 1:30 p.m.
Poster Session: New Antimicrobial Drug Development
Gregory Medlock, PhD
Director, Research
Vedanta Biosciences
Cambridge, Massachusetts, United States
Cintia Felix, MS
Vedanta Biosciences
Cambridge, Massachusetts, United States
Wajd Alsharif, BS
Vedanta Biosciences
Watertown, Massachusetts, United States
Lou Cornacchione, PhD
Vedanta Biosciences
Cambridge, Massachusetts, United States
Matthew Schinn, PhD
Vedanta Biosciences
Cambridge, Massachusetts, United States
Andrea Watson, PhD
Vedanta Biosciences
Cambridge, Massachusetts, United States
Suzanne Bedard-Shurtleff, BS
Vedanta Biosciences
Cambridge, Massachusetts, United States
Jason Norman, PhD
Associate Director
Vedanta Biosciences
Cambridge, MA, United States
Jeremiah Faith, PhD
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Ed J. Kuijper, Prof. Dr.
Professor Medical Microbiolopgy
Leiden University Medical Center and RIVM
Leiden, Zuid-Holland, Netherlands
Bernat Olle, PhD
CEO
Vedanta Biosciences
Cambridge, MA, United States
Silvia Caballero, PhD
Vedanta Biosciences
Cambridge, Massachusetts, United States